AudioScholar Infectious Disease Weekly

By AudioScholar

Infectious Disease — a weekly podcast briefing of the most significant peer-reviewed infectious disease literature, synthesized from PubMed and delivered as ~10-minute audio. For practicing physicians... more

Download on the App Store

Download on the App Store

Get it on Google Play

FAQs about AudioScholar Infectious Disease Weekly:

How many episodes does AudioScholar Infectious Disease Weekly have?

The podcast currently has 7 episodes available.

AudioScholar Infectious Disease Weekly episodes:

June 26, 2026This Week in Infectious Disease — Jun 25, 2026
Welcome to This Week in Infectious Disease. This week we're covering 10 notable papers spanning global outbreak modeling and vector dynamics, novel therapeutic strategies for chronic viral and bacterial infections, and emerging diagnostic and environmental health insights. Let's dive in.
We begin with critical updates on infectious disease epidemiology and vector transmission across the African c…
This week's papers:
Size of the 2026 Ebola outbreak and risk of cross-border spillover from Bundibugyo virus in Ituri Province, DR Congo, and its implications for preparedness: a recalibrated stochastic modelling study. — The Lancet. Infectious diseases 2026
The origin, history, and resistance architecture of an invasive urban malaria mosquito in Africa. — Science 2026
A Streptomyces megacluster encodes synergistic biotin-targeting antibiotics. — Nature 2026
Prevalence and epidemiological patterns of Neisseria gonorrhoeae infection in sub-Saharan Africa, 1964-2025: Systematic review, meta-analyses, and meta-regressions. — PLoS medicine 2026
Klebsiella genus as driver of human disease: from infections to non-communicable disorders. — Nature reviews. Microbiology 2026
FDG-PET/CT Demonstrates Superior Detection of Multiorgan Involvement in Paracoccidioidomycosis Compared with Conventional Staging. — Clinical infectious diseases 2026
WHO estimates of the global, regional, and national disease burden of nine foodborne chemicals, 2000-21: an updated data synthesis. — The Lancet. Global health 2027
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection. — The New England journal of medicine 2026
Effectiveness of the BNT162b2 LP.8.1-adapted SARS-CoV-2 vaccine against COVID-19-associated hospitalisation and death: a Danish nationwide cohort study. — The Lancet. Infectious diseases 2026
An anaerobic pathogen rewires host metabolism to fuel oxidative growth in the inflamed gut. — Cell 2026
Listen at AudioScholar
...more
11min
June 19, 2026This Week in Infectious Disease — Jun 18, 2026
Welcome to This Week in Infectious Disease. This week we're covering 10 notable papers spanning major clinical trials in bacterial infections, new data on vaccine effectiveness for COVID-19 and Mpox, and a look at the future of antimicrobial discovery and global disease surveillance. Let's dive in.
We begin with two important clinical trials that could change how we manage common and serious bact…
This week's papers:
An HIV vaccine blueprint. — Science (New York, N.Y.) 2026
Neutralising antibody responses to MPXV clades Ia, Ib, and IIb after infection or vaccination: a multicountry observational study. — The Lancet. Infectious diseases 2026
Fosfomycin as Oral Transition Therapy Versus Continued Intravenous β-Lactams for Complicated Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacterales: A Multicenter, Open-Label, Randomized Controlled Trial. — Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026
Deep learning-enabled discovery of antibiotics effective against Neisseria gonorrhoeae. — Science translational medicine 2026
Engineered antibodies bypass bacterial immune evasion to drive complement-mediated protection against lethal infections. — Science translational medicine 2026
Estimated Effectiveness of 2024-2025 COVID-19 Vaccines in Adults. — JAMA internal medicine 2026
Analysis of 173,303 exomes and genomes in the Pakistan Genome Resource. — Nature 2026
WHO estimates of the global, regional, and national burden of 14 foodborne diarrhoeal enteric hazards, 2000-21: an updated data synthesis. — The Lancet. Global health 2026
Identification of host gene transcripts by machine learning and their application to predict outcome in Ebola virus disease. — The Journal of infectious diseases 2026
Listen at AudioScholar
...more
11min
June 12, 2026This Week in Infectious Disease — Jun 11, 2026
Welcome to This Week in Infectious Disease. This week we're covering 10 notable papers spanning practical hospital-based infection control, the intricacies of host-virus interactions, and the latest in global health epidemiology and policy. Let's dive in.
We begin with a focus on practical prevention and management of common hospital-associated infections. First, a major paper from The Lancet Inf…
This week's papers:
Cost-effectiveness of Commercial or Traditional Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection. — Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026
SARS-CoV-2 variant booster vaccination and infection alter the breadth of the memory B cell repertoire. — Science translational medicine 2026
GPR15-guided CD8T regulatory cells control intestinal inflammation. — Nature 2026
Understanding sugar-sweetened beverage tax implementation globally: a 34-year, population-based observational study in 183 countries. — The Lancet. Global health 2026
Inclusion of young adolescents in policy development for new tuberculosis vaccines. — The Lancet. Global health 2026
Effectiveness of oral care for the prevention of non-ventilator hospital-acquired pneumonia (HAPPEN): a multicentre, stepped-wedge, cluster-randomised trial in Australia. — The Lancet. Infectious diseases 2026
Zoster Vaccination and Dementia: Interpreting the Signal and Testing the Mechanisms. — Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026
Molecular Epidemiology to Decipher the Transmission Networks of MPOX in an Outbreak Scenario: Applications in Thailand during the 2023 Global Health Emergency. — The Journal of infectious diseases 2026
Implementing the commitments of the World Health Assembly kidney health resolution: a key opportunity to improve health for millions. — Lancet (London, England) 2026
Systematic discovery of pro- and anti-HIV host factors in primary human CD4+ T cells. — Cell 2026
Listen at AudioScholar
...more
11min
June 06, 2026This Week in Infectious Disease — Jun 6, 2026
Welcome to This Week in Infectious Disease. This week we're covering 10 notable papers spanning the global fight against antimicrobial resistance, new insights into host immunology and viral reservoirs, and key updates in prevention and therapeutics. We'll also note two important dispatches from the field on drug-resistant malaria and the Sudan Virus. Let's dive in.
We begin with antimicrobial re…
This week's papers:
Global, regional, and national impact of the Expanded Programme on Immunization against 14 pathogens from 1974 to 2024: an economic evaluation. — The Lancet. Global health 2026
Plasma signals of lung tumor promotion for molecular cancer prevention. — Cell 2026
Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial. — JAMA 2026
A natural depsipeptide antibiotic binds the E-site of the bacterial ribosome. — Nature 2026
Kidney Transplantation in Two Highly Sensitized Candidates after CAR T-Cell Therapy. — The New England journal of medicine 2026
Intravenous Artesunate in Artemisinin-Resistant Severe Malaria in Uganda. — The New England journal of medicine 2026
Sudan Virus Disease in Uganda, 2025. — The New England journal of medicine 2026
HIV-1 infection converts CD4T cells to HLA class II-restricted CD8T cells. — Science translational medicine 2026
Limitations of Global Surveillance for Neisseria gonorrhoeae Antimicrobial Resistance. — Emerging infectious diseases 2026
Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development. — The Lancet. Infectious diseases 2025
Listen at AudioScholar
...more
10min
May 28, 2026This Week in Infectious Disease — May 28, 2026
Welcome to This Week in Infectious Disease. This week we're covering 10 notable papers spanning diagnostics and stewardship, new therapies for major global infections, and key updates in public health and epidemiology. Let's dive in.
[PAUSE]
We begin this week with a focus on diagnostics and antimicrobial stewardship, a constant challenge in an era of rising resistance.
[PAUSE]
The Study
[PAUS…
This week's papers:
Clinical Impact and Cost-Effectiveness of Improving Access to Cryptococcal Meningitis Diagnostics and Treatment in Malawi. — Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection. — The New England journal of medicine 2026
Sustained and indirect effects of PCV10 reduced-dose schedules on pneumococcal carriage in Viet Nam: a long-term follow-up of a cluster-randomised controlled trial. — The Lancet. Infectious diseases 2026
Differences in tuberculosis prevalence by sex in low- and middle-income countries over 1993-2025: A systematic review and meta-analysis. — PLoS medicine 2026
U = U for all: Advancing equity in HIV prevention. — PLoS medicine 2026
Fast Antimicrobial Susceptibility Testing for Gram-Negative Bacteremia: The FAST Randomized Clinical Trial. — JAMA 2026
A combined ELISA for infection-induced and vaccine-induced mpox antibodies during the clade Ib outbreak in Rwanda: an observational, cross-sectional, clinical validation study. — The Lancet. Infectious diseases 2026
Varicella zoster virus and the central nervous system. — Nature reviews. Microbiology 2026
Immediate or high-dose antituberculosis therapy for HIV-related sepsis in Tanzania and Uganda (ATLAS): a phase 3, open-label, randomised, controlled, 2 × 2 factorial, superiority trial. — The Lancet. Infectious diseases 2026
Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation: recommendations from the 10th European Conference on Infections in Leukaemia. — The Lancet. Infectious diseases 2025
Listen at AudioScholar
...more
12min
May 21, 2026This Week in Infectious Disease — May 21, 2026
Welcome to This Week in Infectious Disease. This week we're covering 8 notable papers spanning advances in HIV prevention and management, antimicrobial stewardship in common outpatient infections, and the global landscape of surveillance, new drugs, and prevention. Let's dive in.
[PAUSE]
Our first theme is advances in HIV prevention and management, with three papers from Clinical Infectious Dise…
This week's papers:
Global and regional molecular epidemiology of HIV-1 during 1990-2024: systematic review, global survey, and analysis of prevalence. — The Lancet. Infectious diseases 2026
Azithromycin for Preschoolers with Wheezing in the Emergency Department. — The New England journal of medicine 2026
Multi-Center Real-World Implementation Outcomes of Lenacapavir for HIV Pre-Exposure Prophylaxis. — Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026
Differing Presentations of Excess Visceral Abdominal Fat in People Living With HIV: Two Clinical Cases Highlighting Distinct Therapeutic Pathways With Tesamorelin and Glucagon-Like Peptide-1 Receptor Agonists. — Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026
Quantifying relative health impact across Gavi, the Vaccine Alliance's portfolio in 117 countries at the subregional level: a modelling study. — Lancet (London, England) 2026
Efficacy and safety of cefepime-nacubactam and aztreonam-nacubactam compared with imipenem-cilastatin for complicated urinary tract infection or acute uncomplicated pyelonephritis (Integral-1): a double-blind, randomised phase 3 trial. — Lancet (London, England) 2026
Amoxicillin-Clavulanate vs Amoxicillin for Acute Sinusitis in Adults. — JAMA 2026
Antiretroviral Activity, Pharmacokinetics, and Safety of MK-8527, an Oral Nucleoside Reverse Transcriptase Translocation Inhibitor, in Adults With HIV-1 Who Had Not Previously Taken Antiretroviral Agents: Results From 2 Open-Label, Phase 1 Studies. — Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026
Listen at AudioScholar
...more
13min
May 14, 2026This Week in Infectious Disease — May 14, 2026
Welcome to This Week in Infectious Disease. This week we're covering 8 notable papers spanning global health prevention, neonatal sepsis, and the evolving landscape of viral infections. Let's dive in.
[PAUSE]
Our first theme is rethinking prevention strategies in global health, with new data on tuberculosis, malaria, and schistosomiasis.
[PAUSE]
Two papers this week offer fresh perspectives on…
This week's papers:
Understanding and exploiting superspreading to disrupt Mycobacterium tuberculosis transmission. — The Lancet. Infectious diseases 2026
Post-mortem characterisation of pathogen-specific causes of infection-related deaths in African and south Asian neonates: a prospective, observational, multicentre study. — The Lancet. Infectious diseases 2026
Sex-specific presentation, epidemiology, and control of schistosomiasis in women and adolescent girls. — The Lancet. Global health 2026
Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts. — The New England journal of medicine 2026
Contribution of nosocomial transmission to Klebsiella pneumoniae neonatal sepsis in Africa and South Asia: An observational study of infection clusters inferred from pathogen genomics and temporal data. — PLoS medicine 2026
Global, regional, and national estimates of tuberculosis incidence averted by eliminating undernutrition in adults: a modelling study. — The Lancet. Global health 2026
Impact of introducing RTS,S/AS01malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme. — Lancet (London, England) 2026
Respiratory viral infections prime accelerated lung cancer growth. — Cell 2026
Listen at AudioScholar
...more
11min

FAQs about AudioScholar Infectious Disease Weekly:

How many episodes does AudioScholar Infectious Disease Weekly have?

The podcast currently has 7 episodes available.